A Case of Cerebral Folate Deficiency due to FOLR1 Mutation in a 10-Year-Old Girl: Clinical Presentation and Treatment

Farzad Ahmadabadi1,2, Mahsa Heidari-Foroozan3, Seyed Amin Jazayeri2

  • 1Pediatric Neurology Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.

Clinical Case Reports
|October 24, 2025
PubMed

Insights

Cerebral folate deficiency (CFD) in a child was caused by a FOLR1 gene mutation, impairing brain folate transport. Folinic acid treatment significantly improved her developmental regression and refractory seizures.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Cerebral folate deficiency (CFD) is a neurological disorder characterized by low folate levels in the cerebrospinal fluid (CSF).
  • It often presents with developmental delay, regression, and intractable seizures, particularly in children.
  • Impaired folate transport across the blood-brain barrier is a key pathogenic mechanism.

Purpose of the Study:

  • To report a case of pediatric CFD due to a FOLR1 gene mutation.
  • To highlight the diagnostic utility of genetic testing in CFD.
  • To demonstrate the therapeutic efficacy of folinic acid in this condition.

Main Methods:

  • Case report of a 10-year-old girl with developmental regression and refractory seizures.
  • Whole exome sequencing to identify genetic cause.
  • Initiation of folinic acid supplementation based on diagnosis.

Main Results:

  • A pathogenic mutation in the FOLR1 gene was identified, confirming CFD.
  • The patient experienced significant clinical improvement following folinic acid treatment.
  • Seizure control and developmental progress were observed post-treatment.

Conclusions:

  • Genetic testing is crucial for diagnosing CFD and identifying the underlying genetic defect.
  • Folinic acid supplementation is an effective treatment for CFD caused by FOLR1 mutations.
  • Early diagnosis and treatment can mitigate severe neurological deficits in CFD.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
288
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
693